4
Changes in Ownership
BlossomHill Therapeutics, Inc. Filed Acc 0001772233-26-000005
Executive Chairman acquired 1,838,896 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Li Yishan Executive Chairman | 2026-08-10 | Conversion | +1,600,682 | 1,600,682 | I | ||
| Li Yishan Executive Chairman | 2026-08-10 | Conversion | +113,435 | 1,714,117 | I | ||
| Li Yishan Executive Chairman | 2026-08-10 | Conversion | +124,779 | 124,779 | I | ||
| Derivatives | |||||||
| Li Yishan Executive Chairman | 2026-08-06 | Grant or award · Employee Stock Option (Right to Buy) | +112,701 | 112,701 | D | ||
| Li Yishan Executive Chairman | 2026-08-10 | Conversion · Series Angel Preferred Stock | −1,600,682 | 0 | I | ||
| Li Yishan Executive Chairman | 2026-08-10 | Conversion · Series B Preferred Stock | −113,435 | 0 | I | ||
| Li Yishan Executive Chairman | 2026-08-10 | Conversion · Series B Preferred Stock | −124,779 | 0 | I | ||
Loading xslF345X06/form4-08102026_100812.xml…